The cell analysis market size was valued at USD 17.7 billion in 2021 and is projected to reach USD 28.9 billion by 2030, expanding at a CAGR of around 10% during the forecast period, 2022 – 2030. The growth of the market is attributed to the increased cancer incidence and rising healthcare business.
The study of cells separated from tissues in multicellular and unicellular organisms is referred to as cell analysis. Cellular analysis plays an important role in protein identification epigenomics, gene identification, and other life science-related areas. The study of an organism's genetic and phonotypical traits is a natural process. Cellular analysis is used to assess and quantify cell number, cell condition, cell health & viability, proliferation, as well as chemical and cell-mediated toxicity.
Market Trends, Drivers, Restraints, and Opportunities
- Cell-based assays are becoming popular in drug development, which is projected to drive the market during the forecast period.
- Development of technologically advanced products is anticipated to fuel the market in the coming years.
- Increasing hospitals and diagnostic laboratories in the developing nations is estimated to boost the market.
- Increased government investments in the life sciences industry are expected to propel the market during the projected period.
- High cost of the cell analysis instruments is expected to hamper the market growth.
- Complex and time-consuming regulatory standards are anticipated to hinder the market growth.
- Rapid expansion of biopharmaceutical and biotechnological enterprises is projected to create immense opportunities for the market players.
Scope of the Report
The report on the global cell analysis market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Cell Analysis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2021
|
|
Historic Data
|
2019–2020
|
|
Forecast Period
|
2022 – 2030
|
|
Segmentation
|
Techniques (High Content Screening, Spectrophotometry, Microscopy, Cell Microarrays, PCR, Flow Cytometry, and Others), Products & Services (Service, Software, Accessories, Instruments, and Reagents & Consumables), Process (Single-Cell Analysis, Target Identification & Validation, Cell Structure Study, Cell Interaction, Cell Counting & Quality Control, Cell Proliferation, Cell Signaling Pathways/Signal Transduction, Cell Viability, and Cell Identification), End-users (Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, Pharmaceutical & Biotechnology Companies, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Illumina; 10x Genomics; Corning Incorporated; QIAGEN; CELLINK; Tecan Trading AG; PerkinElmer; Promega Corporation; Meiji Techno; Creative Bioarray; Cell Biolabs; NanoCellect Biomedical; Fluidigm Corporation; BioStatus Limited; Bio-Rad Laboratories; Miltenyi Biotec; Olympus Corporation; Agilent Technologies; Merck KGaA; General Electric; Dickinson and Company; Becton; Thermo Fisher Scientific; and Danaher.
|
Market Segment Insights
The flow cytometry segment held a major market share in 2021
Based on techniques, the market is segregated into high content screening, spectrophotometry, microscopy, cell microarrays, PCR, flow cytometry, and others. The flow cytometry segment held a major market share in 2021. Flow cytometry's widespread use in single-cell analysis is due to its ability to measure several parameters in a heterogeneous sample at the single-cell level, which is estimated to drive the market. The high content screening segment is anticipated to expand at a high CAGR during the forecast period. Increase in cell behavior studies is expected to boost the market. Complexity of cell image collecting and analysis workflows caused by fluorescent illumination is projected to hamper the segment growth.
The software segment is anticipated to expand at a high CAGR during the forecast period
On the basis of products & services, the market is fragmented into service, software, accessories, instruments, and reagents & consumables. The software segment is anticipated to expand at a high CAGR during the forecast period. The growing requirement for computational methodologies and software tools has resulted from the development of datasets with complicated designs and many modalities. The reagents & consumables segment accounted for a major market share in 2021. Flow cytometry reagents are available as direct conjugated products from major market vendors. Introduction of high-quality reagents by key players has boosted the market availability of dry flow cytometry reagents, resulting in the reagents & consumables industry's domination.
The single-cell analysis segment is projected to grow at a rapid pace during the forecast period
In terms of process, the market is divided into single-cell analysis, target identification & validation, cell structure study, cell interaction, cell counting & quality control, cell proliferation, cell signaling pathways/signal transduction, cell viability, and cell identification. The cell identification segment accounted for key market share in 2021. Cell identification is a crucial stage in a variety of industrial applications, such as healthcare and food. Identification of cells is crucial when it comes to medication development, cells are identified depending on how they react to a given molecule. The single-cell analysis segment is projected to grow at a rapid pace during the forecast period. Over the years, single-cell analysis has acquired a lot of popularity as a way to examine individual cells on a multi-parametric level, thus driving the market growth.
The pharmaceutical & biotechnology companies segment held a major market share in 2021
Based on end-users, the market is segregated into academic & research institutes, hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment held a major market share in 2021. The widespread usage of instruments and consumables at various phases of drug research & development is estimated to drive the segment.
North America dominated the market in 2021
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2021. Growth of the market in the region is attributed to favorable business climate, well-established biotechnology & pharmaceutical companies, strong government support, and favorable business environment. Asia Pacific is anticipated to register a high CAGR during the forecast period. The GDPs as well as their disposable incomes of Asia Pacific countries, are growing steadily, which is anticipated to fuel the market.
Segments
The global cell analysis market has been segmented on the basis of
Techniques
- High Content Screening
- Spectrophotometry
- Microscopy
- Cell Microarrays
- PCR
- Flow Cytometry
- Others
Products & Services
- Service
- Software
- Accessories
- Instruments
- Reagents & Consumables
Process
- Single-Cell Analysis
- Target Identification & Validation
- Cell Structure Study
- Cell Interaction
- Cell Counting & Quality Control
- Cell Proliferation
- Cell Signaling Pathways/Signal Transduction
- Cell Viability
- Cell Identification
End-users
- Academic & Research Institutes
- Hospitals & Clinical Testing Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Illumina
- 10x Genomics
- Corning Incorporated
- QIAGEN
- CELLINK
- Tecan Trading AG
- PerkinElmer
- Promega Corporation
- Meiji Techno
- Creative Bioarray
- Cell Biolabs
- NanoCellect Biomedical
- Fluidigm Corporation
- BioStatus Limited
- Bio-Rad Laboratories
- Miltenyi Biotec
- Olympus Corporation
- Agilent Technologies
- Merck KGaA
- General Electric
- Dickinson and Company
- Becton
- Thermo Fisher Scientific
- Danaher
Competitive Landscape
Key players competing in the cell analysis market include Illumina; 10x Genomics; Corning Incorporated; QIAGEN; CELLINK; Tecan Trading AG; PerkinElmer; Promega Corporation; Meiji Techno; Creative Bioarray; Cell Biolabs; NanoCellect Biomedical; Fluidigm Corporation; BioStatus Limited; Bio-Rad Laboratories; Miltenyi Biotec; Olympus Corporation; Agilent Technologies; Merck KGaA; General Electric; Dickinson and Company; Becton; Thermo Fisher Scientific; and Danaher. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,
- In 2022, Becton, Dickinson and Company have introduced a new high-throughput cell separator that combines fluorescence and visual imaging.
- In 2020, the phitonex, inc. was acquired by Thermo Fisher Scientific. This acquisition helped Thermo Fisher Scientific company to increase its imaging multiplexing and flow cytometry capabilities in cell and protein analysis research.
Request For Customization
Enquiry Before Buying
Speak With Analyst
